24 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 24 of 24 clinical reviews.
A physician-reviewed comparison of compounded dulaglutide versus branded Trulicity, covering FDA approval status, clinical trial evidence from REWIND, safety differences, cost, and who qualifies for each option.
A physician-reviewed guide to using dulaglutide (Trulicity) after bariatric surgery, covering pharmacokinetics, dosing, evidence from REWIND and other trials, and practical prescribing considerations for post-bariatric patients with type 2 diabetes.
A clinician-level review of dulaglutide (Trulicity) use in patients with autoimmune conditions, covering thyroid disease, IBD, lupus, RA, and safety signals from REWIND and post-marketing data.
A clinician-level review of how dulaglutide (Trulicity) affects sexual function in men and women with type 2 diabetes, covering the REWIND trial, hormonal pathways, erectile dysfunction, libido changes, and practical management guidance.
A physician-reviewed, primary-literature analysis of dulaglutide's effect on cognition, brain health, and dementia risk in type 2 diabetes, including REWIND trial data and mechanistic research.
A clinical deep-dive into how dulaglutide (Trulicity) changes appetite, food cravings, and eating behavior in type 2 diabetes. Includes trial data, mechanism, dose effects, and practical management.
A clinician-level review of dulaglutide (Trulicity) and its effects on bone mineral density, fracture risk, and skeletal metabolism, with primary-literature citations and practical prescribing guidance.
A physician-level review of dulaglutide (Trulicity) and cancer risk, covering thyroid, pancreatic, and colorectal signals from REWIND, FDA labeling, and post-marketing surveillance data.
A deep-dive into dulaglutide's long-term cardiovascular effects, anchored in the REWIND trial and supporting literature. Learn what a 12% MACE reduction means clinically, who benefits most, and how dulaglutide compares to other GLP-1 receptor agonists.
A GRADE-level analysis of dulaglutide (Trulicity) clinical evidence, covering cardiovascular outcomes, glycemic efficacy, weight, safety, and how the data stacks up for shared decision-making in type 2 diabetes.
A physician-reviewed guide to dulaglutide (Trulicity) effects on hair and skin, covering clinical trial data, proposed mechanisms, and what patients can expect.
A clinical deep-dive into how dulaglutide (Trulicity) affects liver enzymes, hepatic fat, and NAFLD/MASH. Covers REWIND trial data, ALT/AST findings, and prescribing guidance for patients with liver disease.
A clinician-level review of how dulaglutide (Trulicity) affects mental health and mood, covering GLP-1 receptor signaling in the brain, trial data, FDA safety communications, and practical monitoring guidance.
A physician-reviewed deep dive into how dulaglutide (Trulicity) affects metabolism, energy expenditure, thermogenesis, and weight. Includes REWIND trial data, mechanism-of-action details, and clinical dosing guidance.
A clinical review of dulaglutide (Trulicity) microdosing protocols, approved dosing regimens, REWIND trial data, and what physicians should know about off-label low-dose use in type 2 diabetes and weight management.
Evidence-based strategies to preserve lean mass while on Trulicity (dulaglutide), including resistance training protocols, protein targets, and monitoring checkpoints reviewed by HealthRX physicians.
Why dulaglutide (Trulicity) stops working and what to do about it. MD-level plateau troubleshooting covering dose optimization, GLP-1 receptor tachyphylaxis, combination strategies, and switch protocols backed by primary trial data.
Evidence-based guidance on how long to hold dulaglutide (Trulicity) before surgery, why delayed gastric emptying raises aspiration risk, and how to manage blood glucose in the perioperative period.
Stopping dulaglutide (Trulicity) can trigger glycemic rebound, weight regain, and cardiovascular risk recurrence. Learn what the clinical data say, how fast it happens, and how to discontinue safely.
A physician-level review of dulaglutide's effects on kidney function, including REWIND trial data, GFR trajectories, albuminuria outcomes, and clinical guidance for patients with CKD.
When and how to safely restart dulaglutide (Trulicity) after acute illness, hospitalization, or GI upset. Evidence-based dosing protocols, monitoring parameters, and red flags from the REWIND trial and ADA guidelines.
A clinical guide to dulaglutide (Trulicity) seasonal use considerations, covering heat stability, cold-weather injection technique, holiday eating patterns, illness management, and cardiovascular evidence from REWIND.
A physician-reviewed deep dive into how dulaglutide (Trulicity) affects sleep architecture, including GLP-1 receptor distribution in sleep-regulatory brain regions, weight-loss-driven OSA data, and practical clinical guidance.
A clinician-reviewed, week-by-week guide to dulaglutide (Trulicity) in your first month: side effects, blood sugar changes, dosing milestones, and what the evidence from REWIND and AWARD trials actually shows.